ENHANCED ANTI-TUMOR ACTIVITY OF CD19.CAR-NK CELLS BY INCORPORATING IL-27 AFB Biggi; RN Silvestre; JTC Azevedo; MC Tirapelle; KCR Malmegrim; ML Figueiredo; DT Covas; V Picanço-Castro;

NK-SPECIFIC CAR DESIGN IMPROVES NK CYTOTOXICITY AGAINST TUMOR CELLS JTC Azevedo; RN Silvestre; DT Covas; V Picanço-Castro;

ANTI-CD19 CARS ARMED WITH NK RECEPTOR-DERIVED ACTIVATION DOMAINS DEMONSTRATE TO IMPROVE CAR-NK ANTITUMOR EFFECTOR FUNCTION AND ARE DIFFERENTIALLY ENHANCED BY DASATINIB MHD Santos; JTC Azevedo; RN Silvestre; RDT Calado; DT Covas; V Picanç-Castro;